---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-038668"
form_type: "8-K"
ticker: "PPCB"
cik: "0001517681"
company_name: "Propanc Biopharma, Inc."
filed_at: "2023-10-30T23:59:59+00:00"
generated_at: "2026-06-09T05:54:12.175610+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Propanc Biopharma closes $40K convertible note with investor

## Summary
- Closed sale of $40K convertible promissory note to an investor on Oct 29, 2023.
- Note is convertible into common shares at investor's option after 180 days from issuance.
- Funds were received and transaction closed on Oct 29; initially disclosed on Oct 26, 2023.
- Proceeds likely for general working capital; no other material terms changed from prior disclosure.

## SEC filing metadata
- accession: 0001493152-23-038668
- form_type: 8-K
- ticker: PPCB
- cik: 0001517681
- company_name: Propanc Biopharma, Inc.
- filed_at: 2023-10-30T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1517681/000149315223038668/0001493152-23-038668-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1517681/000149315223038668/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-038668
- JSON: https://secwatch.observer/filing/0001493152-23-038668.json
- Plain text: https://secwatch.observer/filing/0001493152-23-038668.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.